Gene therapy restores sight and cures sickle cell disease
There is a line that separates a child who can see the stars from a child who will never see them. For some children, that line is drawn inside their own eyes. A single faulty gene, passed down like a quiet curse, slowly steals the light. The world narrows. Colors fade. Faces become blurry shapes. Then one day, the border is crossed, and there is only darkness on the other side.
For decades, that border seemed final. There was no way back.
Then, in a laboratory at the University of Pennsylvania, three scientists decided to ask a question no one had answered before: What if we could cross back? What if we could rewrite the instruction that caused the darkness? [1]
The Unknown That Sat in Plain Sight
The mystery began with a simple observation. Some children were born with a condition called Leber congenital amaurosis. Their retinas, the thin layer at the back of the eye that captures light, were slowly dying. The cause was a single broken gene, known as RPE65. Without it, the cells could not produce a protein essential for vision. The children went blind.
But here is the strange part: the cells themselves were not dead. They were just waiting. Waiting for a signal that never came.
Jean Bennett, Katherine A. High, and Albert Maguire looked at those waiting cells and saw a door where others saw a wall. They asked: Could we deliver a working copy of the broken gene directly into the eye? Could we use a harmless virus as a delivery truck, packing it with the correct genetic instructions, and send it to the exact cells that needed it? [1]
The tension of the unsolved problem was immense. Gene therapy had failed before. In the late 1990s, a young man named Jesse Gelsinger died during a gene therapy trial at the University of Pennsylvania [1]. The field was scarred. The public was afraid. The scientific community was cautious.
But Bennett, High, and Maguire did not stop. They worked in silence for years. They tested their approach in animals. They refined the delivery vehicle. They measured every risk. [1]
The Moment the Border Shifted
In 2017, the U.S. Food and Drug Administration approved their therapy [2]. It was the first FDA-approved gene therapy for an inherited disease. The treatment, called Luxturna, was not a cure in the sense of erasing the condition. It was a restoration. Children who could barely see light could suddenly recognize faces. Some could read. Some could ride a bike. [1]
The border had been crossed. Not by force, but by precision.
At the 12th annual Breakthrough Prize ceremony in Los Angeles, Bennett, High, and Maguire received $3 million for their work. The prize, often called the “Oscars of Science,” is funded by philanthropists including Sergei Brin, Mark Zuckerberg, Priscilla Chan, Julia and Yuri Milner, and Anne Wojcicki [1]. The ceremony was held on April 18, 2024, at a venue in Santa Monica, California. Hollywood stars like Edward Norton, Ben Affleck, and Robert Downey Jr. walked the red carpet alongside physicists and mathematicians.
But the real story was not on the red carpet. It was in the biology.
The Switch That Changes Blood
Another mystery sat deeper inside the human body. It was a switch that every human being carries, but almost no one notices until it breaks.
When a baby is born, their blood carries a special kind of hemoglobin, called fetal hemoglobin. It grabs oxygen from the mother’s blood with remarkable efficiency. But shortly after birth, a biological switch flips. The body stops making fetal hemoglobin and starts making adult hemoglobin. This is normal. This is healthy.
Unless you have sickle cell disease or beta-thalassemia.
In sickle cell disease, a single mutation in the adult hemoglobin gene causes red blood cells to deform into crescent shapes. They clog vessels, cause devastating pain, and shorten lives. In beta-thalassemia, the body cannot produce enough adult hemoglobin at all. Millions of people worldwide suffer from these conditions.
The mystery was this: What if we could stop the switch from flipping? What if we could keep the body making fetal hemoglobin forever?
Stuart H. Orkin at Harvard Medical School and Swee Lay Thein at King’s College London spent years searching for the regulator—the genetic lever that controls the switch [3][4]. In 2008, Thein identified a key region of DNA called BCL11A [4]. Orkin later proved that this gene acts as the master brake on fetal hemoglobin production [3].
Once the brake was found, the solution became clear. Use CRISPR gene editing to disable BCL11A in blood stem cells. Let fetal hemoglobin flow again. In 2023, the FDA approved Casgevy, the first CRISPR-based therapy for sickle cell disease and beta-thalassemia [2]. Patients who had lived in constant pain suddenly had relief.
Orkin and Thein received the Breakthrough Prize for revealing the switch that made this possible.
The Gene That United Two Diseases
There was a third mystery, and it was perhaps the most puzzling of all.
Amyotrophic lateral sclerosis, or ALS, is a disease that destroys the neurons controlling movement. Patients lose the ability to walk, speak, and eventually breathe. Frontotemporal dementia, or FTD, is a disease that destroys the frontal and temporal lobes of the brain. Patients lose their personality, their judgment, their sense of self.
For years, these were considered separate illnesses. Different symptoms. Different specialists. Different research.
But Rosa Rademakers at the University of Antwerp and Bryan Traynor at the National Institutes of Health noticed something strange [5][6]. Some families had both diseases. Not in different members—in the same family tree. The same mutation seemed to cause both.
In 2011, they identified the culprit: a mutation in the C9orf72 gene [5][6]. It was a repeat expansion, a stutter in the DNA that produced toxic proteins. The discovery unified the two diseases. It explained why they ran together in families. It opened a new door for diagnosis and treatment.
Rademakers and Traynor received the Breakthrough Prize for solving a puzzle that had confused neurologists for decades.
The Mathematics of Breaking Waves
Not all borders are biological. Some are mathematical.
Frank Merle, a mathematician at the University of Cergy-Pontoise in France, spent his career studying nonlinear evolution equations [7]. These are equations that describe how waves behave. Not just ocean waves, but shock waves in air, turbulence in engines, and plasma waves in stars.
The mystery was this: Some waves stay stable. Others suddenly collapse into singularities—points where the wave becomes infinite. Think of a wave that grows taller and taller until it breaks. Merle wanted to know exactly when and why that breaking happens. [7]
His work has applications in aeronautics, where engineers need to predict turbulence around aircraft wings. It applies to fluid dynamics, where pipelines and pumps must handle sudden pressure changes. It even applies to astrophysics, where plasma waves in the sun can erupt into solar flares.
Merle received $3 million for his breakthroughs. He told reporters at the ceremony that science is “one of the foundations of our civilization.”
The Particle That Could Crack Everything
Deep beneath the surface of the Earth, at Fermilab in Illinois, a beam of muons races through a magnetic field. Muons are heavy cousins of electrons. They are unstable. They live for only 2.2 millionths of a second. But in that brief life, they wobble.
The wobble is called the anomalous magnetic moment. It is a number predicted by the Standard Model of particle physics. The Standard Model is the most successful theory ever created. It explains every known particle and force. But it is incomplete. It cannot explain dark matter. It cannot explain why there is more matter than antimatter.
The mystery is this: The measured wobble of the muon does not quite match the prediction. The difference is tiny. But if it is real, it means there are particles or forces that the Standard Model does not know about.
The Muon g-2 collaborations at CERN, Brookhaven National Laboratory, and Fermilab have spent decades measuring this wobble with extraordinary precision [8][9]. David Hertzog, Chris Polly, Lee Roberts, and William Morse are among the hundreds of scientists who contributed. Their work could reveal a crack in the foundation of physics. [8][9]
They received the Breakthrough Prize in Fundamental Physics for their precision measurements.
The Man Who Saw the Strong Force
David J. Gross received the Special Breakthrough Prize in Fundamental Physics for a career that spans half a century. In 1973, at Princeton University, he discovered asymptotic freedom, the property that explains how the strong nuclear force behaves [10]. At very short distances, quarks barely interact. At larger distances, the force becomes so strong that quarks are permanently confined inside protons and neutrons. [10]
This discovery was so fundamental that Gross shared the Nobel Prize in Physics in 2004. But he did not stop. He went on to advance string theory, a framework that attempts to unify all forces of nature into a single description.
Gross told the audience that science is a journey, not a destination. The border keeps moving.
The Geometry Hidden in Particles
A new prize was awarded for the first time in 2026: the Vera Rubin New Frontiers Prize, named after the astronomer who discovered dark matter. It went to Carolina Figueiredo, an early-career theorist.
Figueiredo’s work is deeply abstract. She studies the geometric connections between seemingly unrelated particle physics theories. Her research suggests that the behavior of fundamental particles may not be determined by the fabric of spacetime at all. Instead, it may be governed by underlying geometric structures that exist beneath the visible world.
This is a radical idea. If true, it could reshape how physicists model the universe.
The Red Carpet and the Resistance
The ceremony itself was not just a celebration. It was a statement.
Edward Norton, the actor, told reporters that the United States currently has “the most anti-science administration in US history.” He said it was “especially important” to highlight scientific achievements at this moment. Alex Honnold, the rock climber, added that he hoped political fluctuations were “short-term compared to the long-term effort required to make these kind of gains in human knowledge.”
Sam Altman, the CEO of OpenAI, spoke about how artificial intelligence is accelerating scientific discovery. “Change this fast is really disorienting,” he said. “There will be a lot of big questions that we’ll have to sort through as a society.”
The Breakthrough Foundation was started by Sergei Brin, Mark Zuckerberg and Priscilla Chan, Julia and Yuri Milner, and Anne Wojcicki. The prizes are designed to honor scientists the way Hollywood honors actors. The total prize money for 2026 exceeded $18 million.
The Circle Closes
Let us return to the child who cannot see the stars.
After the treatment, after the gene therapy, after the tiny virus delivered the correct instructions to the cells of the retina, something changed. The border was not erased. It was crossed. The child looked up at the night sky and saw light where there had been only darkness.
The world had changed since the first paragraph. A gene had been delivered. A switch had been flipped. A mutation had been identified. A wave had been predicted. A particle had been measured. A theory had been unified.
The border between what we know and what we cannot see is not fixed. It moves. Every time a scientist asks a question no one has asked before, the line shifts. Every time a child looks up and sees the stars, the line shifts again.
The Oscars of Science are not about the red carpet. They are about the moment someone crosses the border and shows the rest of us how to follow.
Sources
2. U.S. Food and Drug Administration
6. National Institutes of Health
7. University of Cergy-Pontoise
8. CERN